These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26262839)

  • 1. Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.
    Yin Z; Chowdhury S; McKay C; Baniel C; Wright WS; Bentley P; Kaczanowska K; Gildersleeve JC; Finn MG; BenMohamed L; Huang X
    ACS Chem Biol; 2015 Oct; 10(10):2364-72. PubMed ID: 26262839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.
    Sungsuwan S; Wu X; Huang X
    Methods Enzymol; 2017; 597():359-376. PubMed ID: 28935111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.
    Yin Z; Comellas-Aragones M; Chowdhury S; Bentley P; Kaczanowska K; Benmohamed L; Gildersleeve JC; Finn MG; Huang X
    ACS Chem Biol; 2013; 8(6):1253-62. PubMed ID: 23505965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.
    Qin Q; Yin Z; Wu X; Haas KM; Huang X
    Biomaterials; 2016 Sep; 101():189-98. PubMed ID: 27294537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.
    Qiu L; Li J; Yu S; Wang Q; Li Y; Hu Z; Wu Q; Guo Z; Zhang J
    Oncotarget; 2015 Mar; 6(7):5195-203. PubMed ID: 25760071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.
    Yin Z; Nguyen HG; Chowdhury S; Bentley P; Bruckman MA; Miermont A; Gildersleeve JC; Wang Q; Huang X
    Bioconjug Chem; 2012 Aug; 23(8):1694-703. PubMed ID: 22812480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
    Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
    Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
    Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.
    Sungsuwan S; Yin Z; Huang X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17535-44. PubMed ID: 26200668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.
    Richichi B; Thomas B; Fiore M; Bosco R; Qureshi H; Nativi C; Renaudet O; BenMohamed L
    Angew Chem Int Ed Engl; 2014 Oct; 53(44):11917-20. PubMed ID: 25168881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine.
    Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T
    Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
    Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
    Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
    Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
    Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving a Carbohydrate Mimetic Peptide into the clinic.
    Makhoul I; Hutchins L; Emanuel PD; Pennisi A; Siegel E; Jousheghany F; Monzavi-Karbassi B; Kieber-Emmons T
    Hum Vaccin Immunother; 2015; 11(1):37-44. PubMed ID: 25483513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic.
    Wilson RM; Danishefsky SJ
    J Am Chem Soc; 2013 Oct; 135(39):14462-72. PubMed ID: 23944352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.
    Qiu L; Gong X; Wang Q; Li J; Hu H; Wu Q; Zhang J; Guo Z
    Cancer Immunol Immunother; 2012 Nov; 61(11):2045-54. PubMed ID: 22539085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.
    Geraci C; Consoli GM; Galante E; Bousquet E; Pappalardo M; Spadaro A
    Bioconjug Chem; 2008 Mar; 19(3):751-8. PubMed ID: 18293897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.
    Pifferi C; Thomas B; Goyard D; Berthet N; Renaudet O
    Chemistry; 2017 Nov; 23(64):16283-16296. PubMed ID: 28845889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.